Pathwork Diagnostics has hired Sharon Tetlow to be its new chief financial officer. Tetlow previously served as vice president and CFO at Cell Genesys and she was a venture partner at Apax Partners.
Bio-Rad Laboratories has appointed Deborah Neff to its board of directors, the company said in a recent filing with the US Securities and Exchange Commission.
Neff has been president and CEO of Pathwork Diagnostics since 2006. From 2003 to 2006, she was CEO of Predicant Biosciences and from 1988 to 2003, she held management positions at BD Biosciences, a business unit of Becton Dickinson, where she was worldwide president from 1995 until 2003.
23andMe has named Ruben Mesa to serve on its Myeloproliferative Neoplasms research project advisory board. Mesa has been a professor at Mayo Clinic since 2002, where he currently is chair of the Division of Hematology and Medical Oncology.